Escape from Human Immunodeficiency Virus Type 1 (HIV-1) Entry Inhibitors

Escape from Human Immunodeficiency Virus Type 1 (HIV-1) Entry Inhibitors

The human immunodeficiency virus (HIV) enters cells through a series of molecular interactions between the HIV envelope protein and cellular receptors, thus providing many opportunities to block infection. Entry inhibitors are currently being used in the clinic, and many more are under development....

Bibliografiset tiedot
Päätekijät:	Carol D. Weiss, Christopher J. De Feo
Aineistotyyppi:	Artikkeli
Kieli:	English
Julkaistu:	MDPI AG 2012-12-01
Sarja:	Viruses
Aiheet:	resistance entry inhibitor virus entry fusion envelope glycoprotein HIV
Linkit:	http://www.mdpi.com/1999-4915/4/12/3859

Samankaltaisia teoksia

HIV-1 Entry and Membrane Fusion Inhibitors
Tekijä: Tianshu Xiao, et al.
Julkaistu: (2021-04-01)

HIV-1 Diversity in the Envelope Glycoproteins: Implications for Viral Entry Inhibition
Tekijä: Sabrina E. M. Almeida, et al.
Julkaistu: (2013-02-01)

Hantavirus Gn and Gc Envelope Glycoproteins: Key Structural Units for Virus Cell Entry and Virus Assembly
Tekijä: Nicolás Cifuentes-Muñoz, et al.
Julkaistu: (2014-04-01)

Targeting Cell Entry of Enveloped Viruses as an Antiviral Strategy
Tekijä: Elodie Teissier, et al.
Julkaistu: (2010-12-01)

Design of a Bispecific HIV Entry Inhibitor Targeting the Cell Receptor CD4 and Viral Fusion Protein Gp41
Tekijä: Hongxia Yan, et al.
Julkaistu: (2022-05-01)

Approaches for Identification of HIV-1 Entry Inhibitors Targeting gp41 Pocket
Tekijä: Asim K. Debnath, et al.
Julkaistu: (2013-01-01)

Entry inhibitors as arenavirus antivirals
Tekijä: Kruthika Iyer, et al.
Julkaistu: (2024-04-01)

Altered Env conformational dynamics as a mechanism of resistance to peptide-triazole HIV-1 inactivators
Tekijä: Shiyu Zhang, et al.
Julkaistu: (2021-10-01)

Screening and Identification of Lujo Virus Entry Inhibitors From an Food and Drug Administration-Approved Drugs Library
Tekijä: Junyuan Cao, et al.
Julkaistu: (2021-12-01)

Determinants of the Bovine Leukemia Virus Envelope Glycoproteins Involved in Infectivity, Replication and Pathogenesis
Tekijä: Alix de Brogniez, et al.
Julkaistu: (2016-03-01)

A Hyperstabilizing Mutation in the Base of the Ebola Virus Glycoprotein Acts at Multiple Steps To Abrogate Viral Entry
Tekijä: J. Maximilian Fels, et al.
Julkaistu: (2019-08-01)

Herpes Simplex Virus 1 Glycoprotein B from a Hyperfusogenic Virus Mediates Enhanced Cell–Cell Fusion
Tekijä: Katrina A. Gianopulos, et al.
Julkaistu: (2024-02-01)

Henipavirus Mediated Membrane Fusion, Virus Entry and Targeted Therapeutics
Tekijä: Dimitar B. Nikolov, et al.
Julkaistu: (2012-02-01)

Mutations of Glu560 within HIV-1 Envelope Glycoprotein N-terminal heptad repeat region contribute to resistance to peptide inhibitors of virus entry
Tekijä: Chen Yuan, et al.
Julkaistu: (2019-12-01)

A Novel CXCR4 Targeting Protein SDF-1/54 as an HIV-1 Entry Inhibitor
Tekijä: Suiyi Tan, et al.
Julkaistu: (2019-09-01)

Comprehensive Insights into the Molecular Basis of HIV Glycoproteins
Tekijä: Amir Elalouf, et al.
Julkaistu: (2024-09-01)

Identification and characterization of key residues in Zika virus envelope protein for virus assembly and entry
Tekijä: Xiao Ma, et al.
Julkaistu: (2022-12-01)

Further Characterization of the Bifunctional HIV Entry Inhibitor sCD4-FIT45
Tekijä: Alexander Falkenhagen, et al.
Julkaistu: (2017-06-01)

Temsavir Treatment of HIV-1-Infected Cells Decreases Envelope Glycoprotein Recognition by Broadly Neutralizing Antibodies
Tekijä: Marianne Boutin, et al.
Julkaistu: (2022-06-01)

MiniCD4 protein resistance mutations affect binding to the HIV-1 gp120 CD4 binding site and decrease entry efficiency
Tekijä: Grupping Katrijn, et al.
Julkaistu: (2012-05-01)

Characterization of Glycoproteins from Insect-Specific Goutanap and Negev Viruses
Tekijä: Kathakali Das, et al.
Julkaistu: (2020-08-01)

Saikosaponin B2, Punicalin, and Punicalagin in Vitro Block Cellular Entry of Feline Herpesvirus-1
Tekijä: Bin Liu, et al.
Julkaistu: (2024-02-01)

HIV-1 Entry and Prospects for Protecting against Infection
Tekijä: Jean-François Bruxelle, et al.
Julkaistu: (2021-01-01)

Functional and Structural Characterization of Novel Insect-Restricted Negev Viruses and Their Interaction with Host Cells
Tekijä: Alexander Rouvinski
Julkaistu: (2020-08-01)

Real-Time Analysis of Individual Ebola Virus Glycoproteins Reveals Pre-Fusion, Entry-Relevant Conformational Dynamics
Tekijä: Natasha D. Durham, et al.
Julkaistu: (2020-01-01)

Inhibition of human immunodeficiency virus type-1 (HIV-1) glycoprotein-mediated cell-cell fusion by immunor (IM28)
Tekijä: Akoume Marie-Yvonne, et al.
Julkaistu: (2005-02-01)

Role of Hepatitis C Virus Envelope Glycoprotein E1 in Virus Entry and Assembly
Tekijä: Yimin Tong, et al.
Julkaistu: (2018-06-01)

Entry inhibitors: New advances in HCV treatment
Tekijä: Xi-Jing Qian, et al.
Julkaistu: (2016-01-01)

HIV-1 Env trimer opens through an asymmetric intermediate in which individual protomers adopt distinct conformations
Tekijä: Xiaochu Ma, et al.
Julkaistu: (2018-03-01)

Role of Lipids on Entry and Exit of Bluetongue Virus, a Complex Non-Enveloped Virus
Tekijä: Bishnupriya Bhattacharya, et al.
Julkaistu: (2010-05-01)

Extremely Thermostabilizing Core Mutations in Coiled-Coil Mimetic Proteins of HIV-1 gp41 Produce Diverse Effects on Target Binding but Do Not Affect Their Inhibitory Activity
Tekijä: Mario Cano-Muñoz, et al.
Julkaistu: (2021-04-01)

Single Nucleotide Variants of the Human TIM-1 IgV Domain with Reduced Ability to Promote Viral Entry into Cells
Tekijä: Takanari Hattori, et al.
Julkaistu: (2022-09-01)

The Role of Capsid in HIV-1 Nuclear Entry
Tekijä: Anabel Guedán, et al.
Julkaistu: (2021-07-01)

Herpes Simplex Virus Glycoprotein C Regulates Low-pH Entry
Tekijä: Tri Komala Sari, et al.
Julkaistu: (2020-02-01)

Comparison of a Genotype 1 and a Genotype 2 Macaque Foamy Virus <i>env</i> Gene Indicates Distinct Infectivity and Cell-Cell Fusion but Similar Tropism and Restriction of Cell Entry by Interferon-Induced Transmembrane Proteins
Tekijä: Thomas Fricke, et al.
Julkaistu: (2023-01-01)

The Role of Phlebovirus Glycoproteins in Viral Entry, Assembly and Release
Tekijä: Martin Spiegel, et al.
Julkaistu: (2016-07-01)

Current Peptide and Protein Candidates Challenging HIV Therapy beyond the Vaccine Era
Tekijä: Koollawat Chupradit, et al.
Julkaistu: (2017-09-01)

How HIV Takes Advantage of the Cytoskeleton in Entry and Replication
Tekijä: Oliver T. Fackler, et al.
Julkaistu: (2011-03-01)

Natural products as a source of Coronavirus entry inhibitors
Tekijä: Dávid Szabó, et al.
Julkaistu: (2024-02-01)

Virtual Screening, Biological Evaluation, and 3D-QSAR Studies of New HIV-1 Entry Inhibitors That Function via the CD4 Primary Receptor
Tekijä: Chaozai Zhang, et al.
Julkaistu: (2018-11-01)